申请人:Schering Corporation
公开号:US05318971A1
公开(公告)日:1994-06-07
Novel 3-substituted-1-aryl-2(1H)-quinolones useful as anti-allergy, anti-inflammatory, anti-hyperproliferative skin disease agents are disclosed. The quinolones are represented by Formula 1: ##STR1## Pharmaceutical compositions and methods of treatment employing such compounds are also disclosed.
本发明公开了一种作为抗过敏、抗炎症、抗过度增殖皮肤疾病药物的新型3-取代-1-芳基-2(1H)-喹啉酮。这些喹啉酮由式1表示:##STR1## 本发明还公开了使用这些化合物的药物组合物和治疗方法。